aluates Reports

$ 0.0

Automative

Global IL-23p19 Inhibitors Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-23R18295

BUY CHAPTERS

Global IL-23p19 Inhibitors Market Research Report 2024

Code: QYRE-Auto-23R18295

Report

December 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

AbbVie

Merck Sharp& Dohme Corp

Innovent Biologics (Suzhou) Co., Ltd.

Johnson & Johnson

IL-23p19 Inhibitors Market Size

The global market for IL-23p19 Inhibitors was valued at US$ 14080 million in the year 2023 and is projected to reach a revised size of US$ 43230 million by 2030, growing at a CAGR of 15.8% during the forecast period.

IL-23p19 Inhibitors Market

IL-23p19 inhibitors are a class of drugs that work by inhibiting the biological activity of Interleukin-23 (IL-23). IL-23 is a cytokine composed of two subunits, p40 and p19, of which p19 is the specific subunit of IL-23。The mechanism of action of IL-23p19 inhibitors is to prevent IL-23 from binding to its receptor by specifically binding to the p19 subunit of IL-23, thereby disrupting IL-23-mediated signaling pathways and reducing the production of inflammatory factors, such as IL-17, IL-22 and GM-CSF. These factors play an important role in chronic inflammatory diseases.

North American market for IL-23p19 Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for IL-23p19 Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of IL-23p19 Inhibitors include Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for IL-23p19 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-23p19 Inhibitors.

The IL-23p19 Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IL-23p19 Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the IL-23p19 Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of IL-23p19 Inhibitors Market Report

Report Metric	Details
Report Name	IL-23p19 Inhibitors Market
Accounted market size in year	US$ 14080 million
Forecasted market size in 2030	US$ 43230 million
CAGR	15.8%
Base Year	year
Forecasted years	2024 - 2030
by Type	100mg/mL 75mg/mL
by Application	Hospital Clinic Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IL-23p19 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IL-23p19 Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is IL-23p19 Inhibitors Market growing?

Ans: The IL-23p19 Inhibitors Market witnessing a CAGR of 15.8% during the forecast period 2024-2030.

What is the IL-23p19 Inhibitors Market size in 2030?

Ans: The IL-23p19 Inhibitors Market size in 2030 will be US$ 43230 million.

Who are the main players in the IL-23p19 Inhibitors Market report?

Ans: The main players in the IL-23p19 Inhibitors Market are Eli Lilly, AbbVie, Merck Sharp & Dohme Corp., Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson

What are the Application segmentation covered in the IL-23p19 Inhibitors Market report?

Ans: The Applications covered in the IL-23p19 Inhibitors Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the IL-23p19 Inhibitors Market report?

Ans: The Types covered in the IL-23p19 Inhibitors Market report are 100mg/mL, 75mg/mL

Recommended Reports

Immunology Drugs

Diagnostics Testing

Therapeutic Treatments

1 IL-23p19 Inhibitors Market Overview

1.1 Product Definition

1.2 IL-23p19 Inhibitors by Type

1.2.1 Global IL-23p19 Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 100mg/mL

1.2.3 75mg/mL

1.3 IL-23p19 Inhibitors by Application

1.3.1 Global IL-23p19 Inhibitors Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global IL-23p19 Inhibitors Market Size Estimates and Forecasts

1.4.1 Global IL-23p19 Inhibitors Revenue 2019-2030

1.4.2 Global IL-23p19 Inhibitors Sales 2019-2030

1.4.3 Global IL-23p19 Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 IL-23p19 Inhibitors Market Competition by Manufacturers

2.1 Global IL-23p19 Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global IL-23p19 Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global IL-23p19 Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of IL-23p19 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of IL-23p19 Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of IL-23p19 Inhibitors, Product Type & Application

2.7 Global Key Manufacturers of IL-23p19 Inhibitors, Date of Enter into This Industry

2.8 Global IL-23p19 Inhibitors Market Competitive Situation and Trends

2.8.1 Global IL-23p19 Inhibitors Market Concentration Rate

2.8.2 The Global 5 and 10 Largest IL-23p19 Inhibitors Players Market Share by Revenue

2.8.3 Global IL-23p19 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global IL-23p19 Inhibitors Market Scenario by Region

3.1 Global IL-23p19 Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global IL-23p19 Inhibitors Sales by Region: 2019-2030

3.2.1 Global IL-23p19 Inhibitors Sales by Region: 2019-2024

3.2.2 Global IL-23p19 Inhibitors Sales by Region: 2025-2030

3.3 Global IL-23p19 Inhibitors Revenue by Region: 2019-2030

3.3.1 Global IL-23p19 Inhibitors Revenue by Region: 2019-2024

3.3.2 Global IL-23p19 Inhibitors Revenue by Region: 2025-2030

3.4 North America IL-23p19 Inhibitors Market Facts & Figures by Country

3.4.1 North America IL-23p19 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America IL-23p19 Inhibitors Sales by Country (2019-2030)

3.4.3 North America IL-23p19 Inhibitors Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe IL-23p19 Inhibitors Market Facts & Figures by Country

3.5.1 Europe IL-23p19 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe IL-23p19 Inhibitors Sales by Country (2019-2030)

3.5.3 Europe IL-23p19 Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific IL-23p19 Inhibitors Market Facts & Figures by Region

3.6.1 Asia Pacific IL-23p19 Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific IL-23p19 Inhibitors Sales by Region (2019-2030)

3.6.3 Asia Pacific IL-23p19 Inhibitors Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America IL-23p19 Inhibitors Market Facts & Figures by Country

3.7.1 Latin America IL-23p19 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America IL-23p19 Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America IL-23p19 Inhibitors Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa IL-23p19 Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa IL-23p19 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa IL-23p19 Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa IL-23p19 Inhibitors Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global IL-23p19 Inhibitors Sales by Type (2019-2030)

4.1.1 Global IL-23p19 Inhibitors Sales by Type (2019-2024)

4.1.2 Global IL-23p19 Inhibitors Sales by Type (2025-2030)

4.1.3 Global IL-23p19 Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global IL-23p19 Inhibitors Revenue by Type (2019-2030)

4.2.1 Global IL-23p19 Inhibitors Revenue by Type (2019-2024)

4.2.2 Global IL-23p19 Inhibitors Revenue by Type (2025-2030)

4.2.3 Global IL-23p19 Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global IL-23p19 Inhibitors Price by Type (2019-2030)

5 Segment by Application

5.1 Global IL-23p19 Inhibitors Sales by Application (2019-2030)

5.1.1 Global IL-23p19 Inhibitors Sales by Application (2019-2024)

5.1.2 Global IL-23p19 Inhibitors Sales by Application (2025-2030)

5.1.3 Global IL-23p19 Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global IL-23p19 Inhibitors Revenue by Application (2019-2030)

5.2.1 Global IL-23p19 Inhibitors Revenue by Application (2019-2024)

5.2.2 Global IL-23p19 Inhibitors Revenue by Application (2025-2030)

5.2.3 Global IL-23p19 Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global IL-23p19 Inhibitors Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Company Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Eli Lilly IL-23p19 Inhibitors Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 AbbVie

6.2.1 AbbVie Company Information

6.2.2 AbbVie Description and Business Overview

6.2.3 AbbVie IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AbbVie IL-23p19 Inhibitors Product Portfolio

6.2.5 AbbVie Recent Developments/Updates

6.3 Merck Sharp & Dohme Corp.

6.3.1 Merck Sharp & Dohme Corp. Company Information

6.3.2 Merck Sharp & Dohme Corp. Description and Business Overview

6.3.3 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolio

6.3.5 Merck Sharp & Dohme Corp. Recent Developments/Updates

6.4 Innovent Biologics (Suzhou) Co. Ltd.

6.4.1 Innovent Biologics (Suzhou) Co. Ltd. Company Information

6.4.2 Innovent Biologics (Suzhou) Co. Ltd. Description and Business Overview

6.4.3 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolio

6.4.5 Innovent Biologics (Suzhou) Co. Ltd. Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Company Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Johnson & Johnson IL-23p19 Inhibitors Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 IL-23p19 Inhibitors Industry Chain Analysis

7.2 IL-23p19 Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 IL-23p19 Inhibitors Production Mode & Process

7.4 IL-23p19 Inhibitors Sales and Marketing

7.4.1 IL-23p19 Inhibitors Sales Channels

7.4.2 IL-23p19 Inhibitors Distributors

7.5 IL-23p19 Inhibitors Customers

8 IL-23p19 Inhibitors Market Dynamics

8.1 IL-23p19 Inhibitors Industry Trends

8.2 IL-23p19 Inhibitors Market Drivers

8.3 IL-23p19 Inhibitors Market Challenges

8.4 IL-23p19 Inhibitors Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eli Lilly

AbbVie

Merck Sharp& Dohme Corp

Innovent Biologics (Suzhou) Co., Ltd.

Johnson & Johnson

List of Tables

Table 1. Global IL-23p19 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global IL-23p19 Inhibitors Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global IL-23p19 Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global IL-23p19 Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global IL-23p19 Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global IL-23p19 Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global IL-23p19 Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market IL-23p19 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of IL-23p19 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of IL-23p19 Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of IL-23p19 Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of IL-23p19 Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global IL-23p19 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-23p19 Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global IL-23p19 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global IL-23p19 Inhibitors Sales by Region (2019-2024) & (K Units)

Table 18. Global IL-23p19 Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global IL-23p19 Inhibitors Sales by Region (2025-2030) & (K Units)

Table 20. Global IL-23p19 Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global IL-23p19 Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global IL-23p19 Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global IL-23p19 Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global IL-23p19 Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America IL-23p19 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America IL-23p19 Inhibitors Sales by Country (2019-2024) & (K Units)

Table 27. North America IL-23p19 Inhibitors Sales by Country (2025-2030) & (K Units)

Table 28. North America IL-23p19 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America IL-23p19 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe IL-23p19 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe IL-23p19 Inhibitors Sales by Country (2019-2024) & (K Units)

Table 32. Europe IL-23p19 Inhibitors Sales by Country (2025-2030) & (K Units)

Table 33. Europe IL-23p19 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe IL-23p19 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific IL-23p19 Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific IL-23p19 Inhibitors Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific IL-23p19 Inhibitors Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific IL-23p19 Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific IL-23p19 Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America IL-23p19 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America IL-23p19 Inhibitors Sales by Country (2019-2024) & (K Units)

Table 42. Latin America IL-23p19 Inhibitors Sales by Country (2025-2030) & (K Units)

Table 43. Latin America IL-23p19 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America IL-23p19 Inhibitors Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa IL-23p19 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa IL-23p19 Inhibitors Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa IL-23p19 Inhibitors Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa IL-23p19 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa IL-23p19 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global IL-23p19 Inhibitors Sales (K Units) by Type (2019-2024)

Table 51. Global IL-23p19 Inhibitors Sales (K Units) by Type (2025-2030)

Table 52. Global IL-23p19 Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global IL-23p19 Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global IL-23p19 Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global IL-23p19 Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global IL-23p19 Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global IL-23p19 Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2019-2024)

Table 59. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2025-2030)

Table 60. Global IL-23p19 Inhibitors Sales (K Units) by Application (2019-2024)

Table 61. Global IL-23p19 Inhibitors Sales (K Units) by Application (2025-2030)

Table 62. Global IL-23p19 Inhibitors Sales Market Share by Application (2019-2024)

Table 63. Global IL-23p19 Inhibitors Sales Market Share by Application (2025-2030)

Table 64. Global IL-23p19 Inhibitors Revenue (US$ Million) by Application (2019-2024)

Table 65. Global IL-23p19 Inhibitors Revenue (US$ Million) by Application (2025-2030)

Table 66. Global IL-23p19 Inhibitors Revenue Market Share by Application (2019-2024)

Table 67. Global IL-23p19 Inhibitors Revenue Market Share by Application (2025-2030)

Table 68. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2019-2024)

Table 69. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2025-2030)

Table 70. Eli Lilly Company Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Eli Lilly IL-23p19 Inhibitors Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. AbbVie Company Information

Table 76. AbbVie Description and Business Overview

Table 77. AbbVie IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AbbVie IL-23p19 Inhibitors Product

Table 79. AbbVie Recent Developments/Updates

Table 80. Merck Sharp & Dohme Corp. Company Information

Table 81. Merck Sharp & Dohme Corp. Description and Business Overview

Table 82. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product

Table 84. Merck Sharp & Dohme Corp. Recent Developments/Updates

Table 85. Innovent Biologics (Suzhou) Co. Ltd. Company Information

Table 86. Innovent Biologics (Suzhou) Co. Ltd. Description and Business Overview

Table 87. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product

Table 89. Innovent Biologics (Suzhou) Co. Ltd. Recent Developments/Updates

Table 90. Johnson & Johnson Company Information

Table 91. Johnson & Johnson Description and Business Overview

Table 92. Johnson & Johnson IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Johnson & Johnson IL-23p19 Inhibitors Product

Table 94. Johnson & Johnson Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. IL-23p19 Inhibitors Distributors List

Table 98. IL-23p19 Inhibitors Customers List

Table 99. IL-23p19 Inhibitors Market Trends

Table 100. IL-23p19 Inhibitors Market Drivers

Table 101. IL-23p19 Inhibitors Market Challenges

Table 102. IL-23p19 Inhibitors Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of IL-23p19 Inhibitors

Figure 2. Global IL-23p19 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global IL-23p19 Inhibitors Market Share by Type: 2023 & 2030

Figure 4. 100mg/mL Product Picture

Figure 5. 75mg/mL Product Picture

Figure 6. Global IL-23p19 Inhibitors Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global IL-23p19 Inhibitors Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global IL-23p19 Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global IL-23p19 Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 13. Global IL-23p19 Inhibitors Sales (2019-2030) & (K Units)

Figure 14. Global IL-23p19 Inhibitors Average Price (US$/Unit) & (2019-2030)

Figure 15. IL-23p19 Inhibitors Report Years Considered

Figure 16. IL-23p19 Inhibitors Sales Share by Manufacturers in 2023

Figure 17. Global IL-23p19 Inhibitors Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest IL-23p19 Inhibitors Players: Market Share by Revenue in IL-23p19 Inhibitors in 2023

Figure 19. IL-23p19 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global IL-23p19 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America IL-23p19 Inhibitors Sales Market Share by Country (2019-2030)

Figure 22. North America IL-23p19 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 23. United States IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe IL-23p19 Inhibitors Sales Market Share by Country (2019-2030)

Figure 26. Europe IL-23p19 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 27. Germany IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific IL-23p19 Inhibitors Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific IL-23p19 Inhibitors Revenue Market Share by Region (2019-2030)

Figure 34. China IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America IL-23p19 Inhibitors Sales Market Share by Country (2019-2030)

Figure 42. Mexico IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa IL-23p19 Inhibitors Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa IL-23p19 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 48. Turkey IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE IL-23p19 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of IL-23p19 Inhibitors by Type (2019-2030)

Figure 52. Global Revenue Market Share of IL-23p19 Inhibitors by Type (2019-2030)

Figure 53. Global IL-23p19 Inhibitors Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of IL-23p19 Inhibitors by Application (2019-2030)

Figure 55. Global Revenue Market Share of IL-23p19 Inhibitors by Application (2019-2030)

Figure 56. Global IL-23p19 Inhibitors Price (US$/Unit) by Application (2019-2030)

Figure 57. IL-23p19 Inhibitors Value Chain

Figure 58. IL-23p19 Inhibitors Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Janus Kinase Inhibitors Market Research Report 2024

Global Thymidylate Synthase Inhibitor Market Research Report 2024

Global Interleukin 6 Inhibitors for Rheumatoid Arthritis Market Research Report 2024

JAK1 Inhibitor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global VEGF Inhibitors Market Research Report 2024

Global IL 6R Agonist Market Research Report 2024

Global Kinase Inhibitor in Autoimmune Diseases Market Research Report 2024

Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030

Global IL 23 Receptor Antagonist Market Research Report 2024

Global Interleukin 17 Inhibitors Market Research Report 2024

Global IL 2R Inhibitors Market Research Report 2024

Global IL 6R Inhibitor Market Research Report 2024

Global IL 6 Inhibitors Market Research Report 2024

Global IL 17 Inhibitors for Psoriasis Market Research Report 2024

Global IL 17 Targeting Biological Drugs Market Research Report 2024

Global CDK4 6 Inhibitors Market Research Report 2024

Global Janus Kinase inhibitors JAKi Market Research Report 2024

Global Oral JAK Inhibitors Market Research Report 2024

Global Inhibitor of κB Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions